Online citations, reference lists, and bibliographies.

Seven Questions For Personalized Medicine.

Michael J Joyner, Nigel Paneth
Published 2015 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Personalized or precision medicine maintains that medical care and public health will be radically transformed by prevention and treatment programs more closely targeted to the individual patient. These interventions will be developed by sequencing more genomes, creating bigger biobanks, and linking biological information to health data in electronic medical records (EMRs) or obtained by monitoring technologies. Yet the assumptions underpinning personalized medicine have largely escaped questioning. In this Viewpoint, we seek to stimulate a more balanced debate by posing 7 questions for the advocates of personalized medicine.
This paper references



This paper is referenced by
10.7759/cureus.1063
Value-Based Health Care Delivery, Preventive Medicine and the Medicalization of Public Health
Andreas Vilhelmsson (2017)
10.3399/bjgp19X704201
Should UK primary care be an early adopter of genomic medicine?
Donna Dickenson (2019)
10.1515/pubhef-2017-0032
Personalized medicine and global health
Stefan Kohler (2017)
10.1016/j.medin.2017.07.008
Clinical research in critical care. Difficulties and perspectives.
Jaime Latour-Pérez (2018)
10.1353/pbm.2018.0067
Is the Pace of Biomedical Innovation Slowing?
Arturo Casadevall (2018)
10.1001/jama.2015.9629
Is It Possible to Recognize a Major Scientific Discovery?
John P. A. Ioannidis (2015)
10.1016/j.medin.2015.11.006
Distrés respiratorio agudo: del síndrome a la enfermedad
Pablo Cardinal-Fernández (2016)
10.1186/s12913-019-4668-y
The Value Equation: Three complementary propositions for reconciling fidelity and adaptation in evidence-based practice implementation
Ulrica von Thiele Schwarz (2019)
10.1136/medethics-2015-103057
Personal utility is inherent to direct-to-consumer genomic testing
Matthew Wai Heng Chung (2016)
10.1590/0102-311X00153118
Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
Jorge Alberto Bernstein Iriart (2019)
10.1002/cncr.30119
Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay.
Gabrielle Georgiou (2016)
University of Groningen A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes Hertroijs,
Martijn C G J Brouwers (2018)
10.3325/cmj.2019.60.284
Precision medicine and monoclonal antibodies: breach of promise?
Livio Garattini (2019)
10.1155/2016/9795269
Clinically Meaningful Use of Blood Tumor Markers in Oncology
Stefan Holdenrieder (2016)
10.2217/pgs-2018-0126
Precision HIV care: responding to old questions and meeting new challenges.
Todd M. Hulgan (2018)
10.1001/jama.2015.18359
Ushering Hypertension Into a New Era of Precision Medicine.
Theodore Kotchen (2016)
10.1353/pbm.2018.0057
Editors' Introduction to the Special Issue
Nigel Paneth (2018)
10.1177/0962280217702416
Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors
Florent Le Borgne (2018)
10.1016/j.clbc.2020.04.005
Identification of somatic mutations in thirty-year-old serum cell-free DNA from patients with breast cancer: a feasibility study
Mathilde Ritter (2020)
10.1007/s00038-015-0755-y
Molecular and genomic sciences in health: apply the established rules of evidence
Oliver Razum (2015)
10.2217/pgs-2017-0049
Pharmacogenetics and the treatment of functional gastrointestinal disorders.
Houssam Halawi (2017)
Personalizing Medicine: Disease Prevention in silico and in socio
Sara Green (2016)
10.1007/978-3-319-66114-8_28
Specific Issues in Clinical Genetics and Genetic Counselling Practices Related to Inherited Cardiovascular Conditions
Angus John Clarke (2018)
10.1007/s11606-017-4149-0
Evidence-Based Precision Medicine is Needed to Move Toward General Internal Precision Medicine
Evrim Jaccard (2017)
10.1097/ACI.0000000000000426
Biomarkers and asthma management: analysis and potential applications
Levi B. Richards (2018)
10.1001/jamaoto.2016.0678
Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
John S. Schneider (2016)
10.3390/metabo9060108
Translational Metabolomics: Current Challenges and Future Opportunities
Farhana R Pinu (2019)
Pharmacogenetic Testing-An Unfulfilled Promise.
Doug E Campos-Outcalt (2015)
10.1111/jce.13028
Is There a Role for Genetics in the Prevention of Sudden Cardiac Death?
Alessandro Faragli (2016)
10.1093/ije/dyw271
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future
Naomi J Rankin (2016)
10.1016/j.amjmed.2016.11.021
Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease.
Joseph A Ladapo (2017)
10.1176/appi.ajp.163.6.1001
Offspring of Depressed Parents: 30 Years Later.
Myrna M. Weissman (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar